PM
Mhawech-Fauceglia, Paulette
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| IMP3 distinguishes uterine serous carcinoma from endometrial endometrioid adenocarcinoma | American journal of clinical pathology | 2010 | 517 | 0 | |||
| Prognostic significance of neuron-associated protein expression in non-muscle-invasive urothelial bladder cancer | Journal of clinical pathology | 2009 | 517 | 0 | |||
| 14-3-3sigma expression and prognostic value in patients with epithelial ovarian carcinoma: a high throughput tissue microarray analysis | European journal of surgical oncology | 2009 | 486 | 0 | |||
| Submission of the entire lymph node dissection for histologic examination in gynecologic-oncologic specimens. Clinical and pathologic relevance | Gynecologic oncology | 2009 | 585 | 0 | |||
| Role of the tumour necrosis family ligand APRIL in solid tumour development: Retrospective studies in bladder, ovarian and head and neck carcinomas | European journal of cancer | 2008 | 579 | 0 | |||
| No association of NAD(P)H quinone oxidoreductase 1 expression with p53 expression or tumour outcome in patients with superficial and minimally invasive urothelial bladder cancers | BJU international | 2008 | 462 | 0 | |||
| The attitude and knowledge of cervical cancer by Cameroonian women; a clinical survey conducted in Maroua, the capital of Far North Province of Cameroon | International journal of gynecological cancer | 2008 | 638 | 2 | |||
| Prostate-specific membrane antigen expression is a potential prognostic marker in endometrial adenocarcinoma | Cancer epidemiology, biomarkers & prevention | 2008 | 598 | 0 | |||
| Association of TSC1/hamartin, 14-3-3sigma, and p27 expression with tumor outcomes in patients with pTa/pT1 urothelial bladder carcinoma | American journal of clinical pathology | 2008 | 561 | 0 | |||
| Intraobserver and interobserver variability in distinguishing between endocervical and endometrial adenocarcinoma on problematic cases of cervical curettings | International journal of gynecological pathology | 2008 | 559 | 0 | |||
| Pax-5 immunoexpression in various types of benign and malignant tumours: a high-throughput tissue microarray analysis | Journal of clinical pathology | 2007 | 554 | 0 | |||
| Value of ezrin, maspin and nm23-H1 protein expressions in predicting outcome of patients with head and neck squamous-cell carcinoma treated with radical radiotherapy | Journal of clinical pathology | 2007 | 613 | 0 | |||
| Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness | Blood | 2007 | 218 | 217 | |||
| Clinical and Pathological Predictive Factors in Women with Adult-type Granulosa Cell Tumor of the Ovary | International journal of gynecological pathology | 2007 | 574 | 0 | |||
| Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique | Histopathology | 2007 | 645 | 0 | |||
| Predicting outcome in minimally invasive (T1a and T1b) urothelial bladder carcinoma using a panel of biomarkers: a high throughput tissue microarray analysis | BJU international | 2007 | 546 | 0 | |||
| Friend leukaemia integration-1 expression in malignant and benign tumours: a multiple tumour tissue microarray analysis using polyclonal antibody | Journal of clinical pathology | 2007 | 528 | 0 | |||
| Raf1, Aurora-A/STK15 and E-cadherin biomarkers expression in patients with pTa/pT1 urothelial bladder carcinoma; a retrospective TMA study of 246 patients with long-term follow-up | European journal of surgical oncology | 2006 | 600 | 0 | |||
| Diagnostic utility of FLI-1 monoclonal antibody and dual-colour, break-apart probe fluorescence in situ (FISH) analysis in Ewing's sarcoma/primitive neuroectodermal tumour (EWS/PNET). A comparative study with CD99 and FLI-1 polyclonal antibodies | Histopathology | 2006 | 611 | 0 | |||
| FGFR3 and p53 protein expressions in patients with pTa and pT1 urothelial bladder cancer | European journal of surgical oncology | 2006 | 573 | 0 | |||
| EB-D fibronectin expression in squamous cell carcinoma of the head and neck | Oral oncology | 2005 | 640 | 635 | |||
| Mucoepidermoid carcinoma of Stensen's duct: a case report and review of the literature | Head & neck | 2005 | 588 | 911 | |||
| Human achaete-scute Homologue (hASH1) mRNA Level as a Diagnostic Marker to Distinguish Esthesioneuroblastoma From Poorly Differentiated Tumors Arising in the Sinonasal Tract | American journal of clinical pathology | 2004 | 681 | 599 | |||
| Motility-related protein-1 (MRP-1/CD9) expression can predict disease-free survival in patients with squamous cell carcinoma of the head and neck | British journal of cancer | 2004 | 623 | 293 | |||
| Motility-related protein 1 (MRP-1/CD9) expression in urothelial bladder carcinoma and its relation to tumor recurrence and progression | Cancer | 2003 | 574 | 236 | |||
| Value of immunohistochemistry in staging T1 urothelial bladder carcinoma | European urology | 2002 | 536 | 1 |
